gvtcx

Hereditary Angioedema

NHS England Published 20 Jul 2022 Contracts Finder

key details

Value£74,500,000
Statuscomplete
Category (CPV) 33600000 +2 more
RegionScotland, Northern Ireland
Deadline16 Mar 2022
Contract start1 Jul 2022
Contract end31 Dec 2023
Procedureopen
SME suitableYes
OCIDocds-b5fd17-5242c430-9651-453d-9ccd-71a66de32b6f

Awards (10)

This procurement was awarded to 10 suppliers. Values shown are per-award; the notice total is £74,500,000.

SupplierValueDateStatus
Accord-UK Ltd shared £74,500,000 19 Jun 2022 active
BioCryst Ireland Limited shared £74,500,000 19 Jun 2022 active
Celix Pharma Ltd. shared £74,500,000 19 Jun 2022 active
Cipla shared £74,500,000 19 Jun 2022 active
CSL Behring UK Ltd shared £74,500,000 19 Jun 2022 active
Martindale Pharma shared £74,500,000 19 Jun 2022 active
Pharming Group shared £74,500,000 19 Jun 2022 active
Piramal Critical care Limited shared £74,500,000 19 Jun 2022 active
Takeda UK Ltd shared £74,500,000 19 Jun 2022 active
Wockhardt UK Limited shared £74,500,000 19 Jun 2022 active

description

NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
9 Feb 2022 Tender (tender) · a5f89f1b-088d-474b-a1ac-65f1ead8c3f0-508539
20 Jul 2022 Award (award) · 1132440f-b206-4c8a-9c65-84276d8d2f77-556317

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.